2. Klag MJ, Whelton PK, Seider AJ. Decline in US stroke mortality : Demographic trends and antihypertensive treatment. Stroke 1989;20:14-21.
3. Cooper R, Sempos C, Hsieh S-C, Kovar MG. Slowdown in the decline of stroke mortality in the United States, 1978-1986. Stroke 1990;21:1274-1279.
4. Gillum RF. Cerebrovascular disease morbidity in the United States, 1970-1983:Age, sex, region, and vascular surgery. Stroke 1986;17:656-651.
5. Wolf PA, D'agostino RB. Epidemiology of stroke. Stroke. Pathophysiology, diagnosis, and management 1998;3rd ed. New York: Churchill Livingstone. 3-28.
12. Lee BI, Nam HS, Heo JH, Kim DI. The Yonsei Stroke Team. Yonsei Stroke Registry. Cerebrovasc dis 2001;12:145-151.
15. McGovern PG, Burke GL, Sprafka JM. Trends in morbidity, mortality and risk factor levels for stroke from 1960 through 1990 : The Minnesota Heart Survey. JAMA 1992;268:753-759.
16. Collins R, MacMahon S. Blood pressure, antihypertensive treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-298.
18. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981;12:474-477.
19. Ahmed OI, Orchard JT, Sharma R, Mitchell H, Talbo E. Declining mortality from stroke in Allegheny Country, Pennsylvania : Trends in case fatality and severity of disease, 1971-1980. Stroke 1988;19:181-184.
20. Ueda K, Hasuo Y, Kiyohara Y. Intracerebral hemorrhage in a Japanese community, Hisayama : Incidence, changing pattern during longterm follow-up, and related factors. Stroke 1988;19:48-52.
21. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
25. Kim JS, Yoon SS. Perspectives of Stroke in Persons Living in Seoul, South Korea, A survey of 1,000 Subjects. Stroke 1997;28:1165-1169.